Literature DB >> 28526690

Emerging concepts in biliary repair and fibrosis.

Luca Fabris1,2,3, Carlo Spirli2,3, Massimiliano Cadamuro3,4, Romina Fiorotto2,3, Mario Strazzabosco2,3,4.   

Abstract

Chronic diseases of the biliary tree (cholangiopathies) represent one of the major unmet needs in clinical hepatology and a significant knowledge gap in liver pathophysiology. The common theme in cholangiopathies is that the target of the disease is the biliary tree. After damage to the biliary epithelium, inflammatory changes stimulate a reparative response with proliferation of cholangiocytes and restoration of the biliary architecture, owing to the reactivation of a variety of morphogenetic signals. Chronic damage and inflammation will ultimately result in pathological repair with generation of biliary fibrosis and clinical progression of the disease. The hallmark of pathological biliary repair is the appearance of reactive ductular cells, a population of cholangiocyte-like epithelial cells of unclear and likely mixed origin that are able to orchestrate a complex process that involves a number of different cell types, under joint control of inflammatory and morphogenetic signals. Several questions remain open concerning the histogenesis of reactive ductular cells, their role in liver repair, their mechanism of activation, and the signals exchanged with the other cellular elements cooperating in the reparative process. This review contributes to the current debate by highlighting a number of new concepts derived from the study of the pathophysiology of chronic cholangiopathies, such as congenital hepatic fibrosis, biliary atresia, and Alagille syndrome.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  cholangiopathies; ductular reaction; hepatic progenitor cells; macrophages; myofibroblasts

Mesh:

Year:  2017        PMID: 28526690      PMCID: PMC5582882          DOI: 10.1152/ajpgi.00452.2016

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  153 in total

Review 1.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

2.  Elevated interleukin-8 in bile of patients with primary sclerosing cholangitis.

Authors:  Serge J Zweers; Alexey Shiryaev; Mina Komuta; Mette Vesterhus; Johannes R Hov; María J Perugorria; D Rudi de Waart; Jung-Chin Chang; Shanna Tol; Anje A Te Velde; Wouter J de Jonge; Jesus M Banales; Tania Roskams; Ulrich Beuers; Tom H Karlsen; Peter L Jansen; Frank G Schaap
Journal:  Liver Int       Date:  2016-03-16       Impact factor: 5.828

3.  IL-33 facilitates oncogene-induced cholangiocarcinoma in mice by an interleukin-6-sensitive mechanism.

Authors:  Daisaku Yamada; Sumera Rizvi; Nataliya Razumilava; Steven F Bronk; Jaime I Davila; Mia D Champion; Mitesh J Borad; Jorge A Bezerra; Xin Chen; Gregory J Gores
Journal:  Hepatology       Date:  2015-03-20       Impact factor: 17.425

4.  NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway.

Authors:  Ryan McDaniell; Daniel M Warthen; Pedro A Sanchez-Lara; Athma Pai; Ian D Krantz; David A Piccoli; Nancy B Spinner
Journal:  Am J Hum Genet       Date:  2006-05-10       Impact factor: 11.025

5.  Molecular pathways: YAP and TAZ take center stage in organ growth and tumorigenesis.

Authors:  Stefano Piccolo; Michelangelo Cordenonsi; Sirio Dupont
Journal:  Clin Cancer Res       Date:  2013-06-24       Impact factor: 12.531

6.  The bone marrow functionally contributes to liver fibrosis.

Authors:  Francesco P Russo; Malcolm R Alison; Brian W Bigger; Eunice Amofah; Aikaterini Florou; Farhana Amin; George Bou-Gharios; Rosemary Jeffery; John P Iredale; Stuart J Forbes
Journal:  Gastroenterology       Date:  2006-05       Impact factor: 22.682

Review 7.  Emerging roles of Notch signaling in liver disease.

Authors:  Fabian Geisler; Mario Strazzabosco
Journal:  Hepatology       Date:  2014-09-19       Impact factor: 17.425

8.  Stabilization of beta-catenin affects mouse embryonic liver growth and hepatoblast fate.

Authors:  Thomas Decaens; Cécile Godard; Aurélien de Reyniès; David S Rickman; François Tronche; Jean-Pierre Couty; Christine Perret; Sabine Colnot
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

9.  Characterization of hepatic stellate cells, portal fibroblasts, and mesothelial cells in normal and fibrotic livers.

Authors:  Ingrid Lua; Yuchang Li; Jessica A Zagory; Kasper S Wang; Samuel W French; Jean Sévigny; Kinji Asahina
Journal:  J Hepatol       Date:  2016-01-19       Impact factor: 25.083

10.  Notch2 signaling promotes biliary epithelial cell fate specification and tubulogenesis during bile duct development in mice.

Authors:  Jan S Tchorz; Jochen Kinter; Matthias Müller; Luigi Tornillo; Markus H Heim; Bernhard Bettler
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

View more
  29 in total

Review 1.  Human-relevant preclinical in vitro models for studying hepatobiliary development and liver diseases using induced pluripotent stem cells.

Authors:  Pooja Chaudhari; Lipeng Tian; Zhaohui Ye; Yoon-Young Jang
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-26

Review 2.  Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases.

Authors:  Luca Fabris; Romina Fiorotto; Carlo Spirli; Massimiliano Cadamuro; Valeria Mariotti; Maria J Perugorria; Jesus M Banales; Mario Strazzabosco
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-08       Impact factor: 46.802

3.  If It Looks Like a Duct and Acts Like a Duct: On the Role of Reprogrammed Hepatocytes in Cholangiopathies.

Authors:  Kari Nejak-Bowen
Journal:  Gene Expr       Date:  2019-08-22

4.  Src kinase inhibition reduces inflammatory and cytoskeletal changes in ΔF508 human cholangiocytes and improves cystic fibrosis transmembrane conductance regulator correctors efficacy.

Authors:  Romina Fiorotto; Mariangela Amenduni; Valeria Mariotti; Luca Fabris; Carlo Spirli; Mario Strazzabosco
Journal:  Hepatology       Date:  2018-01-26       Impact factor: 17.425

5.  Proteasomal Degradation of Enhancer of Zeste Homologue 2 in Cholangiocytes Promotes Biliary Fibrosis.

Authors:  Nidhi Jalan-Sakrikar; Thiago M De Assuncao; Guang Shi; Sayed Obaidullah Aseem; Cheng Chi; Vijay H Shah; Robert C Huebert
Journal:  Hepatology       Date:  2019-06-22       Impact factor: 17.425

6.  Targeted Apoptosis of Ductular Reactive Cells Reduces Hepatic Fibrosis in a Mouse Model of Cholestasis.

Authors:  Adiba I Azad; Anuradha Krishnan; Leia Troop; Ying Li; Tomohiro Katsumi; Kevin Pavelko; Enis Kostallari; Maria Eugenia Guicciardi; Gregory J Gores
Journal:  Hepatology       Date:  2020-09       Impact factor: 17.425

7.  Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor Deficiency Promotes the Ductular Reaction, Macrophage Accumulation, and Hepatic Fibrosis in the Abcb4-/- Mouse.

Authors:  Anuradha Krishnan; Tomohiro Katsumi; Maria E Guicciardi; Adiba I Azad; Nazli B Ozturk; Christy E Trussoni; Gregory J Gores
Journal:  Am J Pathol       Date:  2020-03-30       Impact factor: 4.307

Review 8.  The Spectrum of Reactive Cholangiocytes in Primary Sclerosing Cholangitis.

Authors:  Maria Eugenia Guicciardi; Christy E Trussoni; Nicholas F LaRusso; Gregory J Gores
Journal:  Hepatology       Date:  2020-02       Impact factor: 17.425

Review 9.  New insights on the role of vascular endothelial growth factor in biliary pathophysiology.

Authors:  Valeria Mariotti; Romina Fiorotto; Massimiliano Cadamuro; Luca Fabris; Mario Strazzabosco
Journal:  JHEP Rep       Date:  2021-02-04

Review 10.  Fibrotic Events in the Progression of Cholestatic Liver Disease.

Authors:  Hanghang Wu; Chaobo Chen; Siham Ziani; Leonard J Nelson; Matías A Ávila; Yulia A Nevzorova; Francisco Javier Cubero
Journal:  Cells       Date:  2021-05-05       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.